How it helps
With best-fit primary endpoints and I/E criteria, you not only streamline clinical planning but build studies with more predictable timelines. Protocol SmartDesign provides a centralized platform that facilitates effective communication; teams can review, refine, and finalize the protocol, all in one place.
How it works
Our advanced AI models mine 60,000 data sources — starting with our gold-standard Sitetrove and Trialtrove data — to generate endpoint and I/E recommendations specific to your trial. This computerized process is supplemented with human oversight: 50 analysts with specialized focus areas, including clinical expertise, aggregate and curate the data to ensure the accuracy of recommendations.
Why it matters
According to a study by the Tufts Center for the Study of Drug Development (Tufts CSDD), 57% of protocols had at least one substantial amendment, nearly half of these which were deemed avoidable. The study also found that the cost to implement a substantial amendment was $141,000 for a Phase II protocol and $535,000 for a Phase III protocol.
For the best experience, please take the interactive demo on a laptop or desktop device.
View source information on which each recommendation is based
Share protocols with key stakeholders in a single platform
See forecasted trial duration, based on historical and performance data
Edit recommended I/E criteria, and forecasted enrollment rate and trial duration will update
Find out how this powerful tool can optimize clinical trial planning.
